The combined dexamethasone/CRH test as a potential surrogate marker in depression
The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950010008002 · Cited by 12,370
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Self-citationSurrogate End Points in Clinical Trials: Are We Being Misled?
Fleming, T. R., & DeMets, D. L. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-7-199610010-00011 · Cited by 1,651
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197
Antidepressants and Hypothalamic-Pituitary-Adrenocortical Regulation
HOLSBOER, F., & BARDEN, N. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-2-187 · Cited by 852
Self-citationThe combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
Self-citationHealth care costs associated with depressive and anxiety disorders in primary care
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.3.352 · Cited by 555 · cited 1×
“When considering direct medical costs and indirect economic losses due to missed work days and decreased income, depression takes a major share of the overall healthcare expenditures in industrialized countries (Simon et al., 1995; Thompson and Richardson, 1999).”
BackgroundInfluentialThe Dexamethasone Suppression Test for Diagnosis and Prognosis in Psychiatry: Commentary and Review
Arana, G. W. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790350067012 · Cited by 526 · cited 1×
“Arana and Ornsteen (1985) reviewed the DST in more than 5000 depressed patients and reported an overall sensitivity of only about 44%.”
BackgroundGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Zobel, A. W., Nickel, T., Sonntag, A., Uhr, M., Holsboer, F., & Ising, M. (2001) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00013-9 · Cited by 354 · cited 5×
“Preliminary clinical studies suggest therapeutic efficacy for the CRH R1 antagonist NBI 30775 (Zobel et al., 2001) in major depression and for the GR antagonist C1073 in psychotic depression (Belanoff et al.”
BackgroundInfluentialSelf-citation
Cited by
The link between childhood trauma and depression: insights from HPA axis studies in humans
Heim, C., Newport, D. J., Mletzko, T., Miller, A. H., & Nemeroff, C. B. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.008 · Cited by 1,704
Russell, G., & Lightman, S. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0228-0 · Cited by 1,032
Binder, E. B. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.021 · Cited by 968
“Clinical studies have shown that a resolution of the HPA-axis hyperactivity and GR insensitivity precedes clinical improvement to antidepressant drugs in patients (Akil et al., 1993; Heuser et al., 1996; Holsboer et al., 1982; Horstmann et al., 2009; Ising et al., 2005, 2007; Schule et al., 2009).”
BackgroundSelf-citationSex differences in stress-related psychiatric disorders: neurobiological perspectives
Bangasser, D. A., & Valentino, R. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.03.008 · Cited by 737
Pace, T. W. W., Hu, F., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.08.009 · Cited by 621
Stress Hormone Regulation: Biological Role and Translation into Therapy
Holsboer, F., & Ising, M. (2010) · Annual Review of Psychology · doi:10.1146/annurev.psych.093008.100321 · Cited by 473
“…depression, as normalization of subsequent test results predicts beneficial clinical outcome (Appelhof et al. 2006; Binder et al. 2009; Hatzinger et al. 2002; Hennings et al. 2009; Heuser et al. 1994; Holsboer-Trachsler et al. 1991; Ising et al. 2005, 2007a; Schüle et al. 2009; Zobel et al. 1999).”
BackgroundSelf-citationMikulska, J., Juszczyk, G., Gawrońska-Grzywacz, M., & Herbet, M. (2021) · Brain Sciences · doi:10.3390/brainsci11101298 · Cited by 450
Joëls, M., Sarabdjitsingh, R. A., & Karst, H. (2012) · Pharmacological Reviews · doi:10.1124/pr.112.005892 · Cited by 425
Holsboer, F., & Ising, M. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.12.032 · Cited by 382
Self-citationJesulola, E., Micalos, P., & Baguley, I. J. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.025 · Cited by 379
Neurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in Bioscience · doi:10.2741/3598 · Cited by 366
Etiology of Depression: Genetic and Environmental Factors
Saveanu, R. V., & Nemeroff, C. B. (2012) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.12.001 · Cited by 356
Chen, C.-H., Ridler, K., Suckling, J., Williams, S., Fu, C. H. Y., Merlo-Pich, E., & Bullmore, E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.018 · Cited by 354
Heim, C., Mletzko, T., Purselle, D., Musselman, D. L., & Nemeroff, C. B. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.002 · Cited by 353
Hellemans, K. G. C., Sliwowska, J. H., Verma, P., & Weinberg, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.06.004 · Cited by 347
Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., Künzel, H. E., Pfennig, A., Uhr, M., & Holsboer, F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.07.039 · Cited by 341
Self-citationPolymorphisms of the Glucocorticoid Receptor Gene and Major Depression
van Rossum, E. F. C., Binder, E. B., Majer, M., Koper, J. W., Ising, M., Modell, S., Salyakina, D., Lamberts, S. W. J., & Holsboer, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.007 · Cited by 324
Self-citationIsing, M., Depping, A., Siebertz, A., Lucae, S., Unschuld, P. G., Kloiber, S., Horstmann, S., Uhr, M., Müller‐Myhsok, B., & Holsboer, F. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06332.x · Cited by 312
Self-citationDepression during pregnancy and postpartum: Contribution of stress and ovarian hormones
Brummelte, S., & Galea, L. A. M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.09.006 · Cited by 308
Cortisol and major depressive disorder-translating findings from humans to animal models and Back
Nandam, L. S., Brazel, M., Zhou, M., & Jhaveri, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00974 · Cited by 265
Heim, C. (2009) · Frontiers in Behavioral Neuroscience · doi:10.3389/neuro.08.041.2009 · Cited by 245
Mantella, R. C., Butters, M. A., Amico, J. A., Mazumdar, S., Rollman, B. L., Begley, A. E., Reynolds, C. F., & Lenze, E. J. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.03.002 · Cited by 222
“Furthermore, more recently the sensitivity of the DST has been brought to question (Heuser et al., 1994; Ising et al., 2005; Watson et al., 2006).”
BackgroundHennings, J. M., Owashi, T., Binder, E. B., Horstmann, S., Menke, A., Kloiber, S., Dose, T., Wollweber, B., Spieler, D., Messer, T., et al. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.05.002 · Cited by 195
Self-citationNeuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?
Griebel, G., & Holsboer, F. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3702 · Cited by 194
Self-citationChen, C., Nakagawa, S., An, Y., Ito, K., Kitaichi, Y., & Kusumi, I. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2016.12.001 · Cited by 191
“However, patients with depression show hyperresponsive increases in CORT levels in the dexamethasone/CRH test (Ising et al 2005; Stetler and Miller 2011; Belvederi Murri et al 2014), which is more pronounced in aged and female patients (Kunugi et al 2006), and demonstrate an overall increased CORT…”
The cortisol awakening response and major depression: examining the evidence
Dedovic, K., & Ngiam, J. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s62289 · Cited by 191
“89,90 Indeed, the current gold standard is the dexamethasone/corticotrophin-releasing hormone (DEX/CRH) test, 89,90 and it has been shown that persisting cortisol hypersecretion on DEX/CRH test enhances the risk for relapse within the following 6 months.”
Stratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.010 · Cited by 186
“The escape from suppression by the synthetic glucocorticoid dexamethasone has assisted in diagnosis of cortisol resistance at the pituitary level (Ising et al., 2005).”
BackgroundSelf-citationNumakawa, T., Adachi, N., Richards, M., Chiba, S., & Kunugi, H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.09.073 · Cited by 181
Actions of Brain-Derived Neurotrophic Factor and Glucocorticoid Stress in Neurogenesis
Numakawa, T., Odaka, H., & Adachi, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112312 · Cited by 173
“abnormally increased levels of GCs [6,7], and such an increased GCs has a role in the onset of mental disorders, including post-traumatic stress disorder and major depressive disorders [8–11].”
BackgroundNeuroendocrinological mechanisms of actions of antidepressant drugs
Schüle, C. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01516.x · Cited by 167
Rohleder, N., Wolf, J. M., & Wolf, O. T. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.12.003 · Cited by 150
Reppermund, S., Zihl, J., Lucae, S., Horstmann, S., Kloiber, S., Holsboer, F., & Ising, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.027 · Cited by 147
Self-citationFlandreau, E. I., Ressler, K. J., Owens, M. J., & Nemeroff, C. B. (2012) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.04.014 · Cited by 143
Dunlop, B. W., Binder, E. B., Cubells, J. F., Goodman, M. M., Kelley, M. E., Kinkead, B., Kutner, M., Nemeroff, C. B., Newport, D. J., Owens, M. J., et al. (2012) · Trials · doi:10.1186/1745-6215-13-106 · Cited by 136
“In many patients with MDD, however, this test induces substantial increases in plasma ACTH and cortisol concentrations [94].”
Self-citationStress, Memory, and the Hippocampus
Wingenfeld, K., & Wolf, O. T. (2014) · Frontiers of Neurology and Neuroscience · doi:10.1159/000356423 · Cited by 139
Findling, J. W., & Raff, H. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0946 · Cited by 134
The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD
Almeida, F. B., Pinna, G., & Barros, H. M. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115495 · Cited by 130
“disorders as well as several medical conditions [19].”
BackgroundEmotional reactivity and internalizing symptoms: Moderating role of emotion regulation
Shapero, B. G., Abramson, L. Y., & Alloy, L. B. (2016) · Cognitive Therapy and Research · doi:10.1007/s10608-015-9722-4 · Cited by 114
“For example, research highlights that HPA dysregulation may occur at the glucocorticoid receptor site and that those with MDD have a reduced efficiency of these receptors that serve as the conduit for recovery of the stress system (Ising et al. 2005).”
BackgroundPharmacogenetics of antidepressants
Crisafulli, C., Fabbri, C., Porcelli, S., Drago, A., Spina, E., De Ronchi, D., & Serretti, A. (2011) · Frontiers in Pharmacology · doi:10.3389/fphar.2011.00006 · Cited by 113
The impact of treatment on HPA axis activity in unipolar major depression
McKay, M. S., & Zakzanis, K. K. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.07.012 · Cited by 103
“DST, DEX/CRH suppression tests (e.g. Ribeiro et al., 1993; Ising et al., 2005)) have been the subject of other meta-analyses.”
BackgroundEvidence for the role of corticotropin-releasing factor in major depressive disorder
Waters, R. P., Rivalan, M., Bangasser, D. A., Deussing, J. M., Ising, M., Wood, S. K., Holsboer, F., & Summers, C. H. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.011 · Cited by 93
“These disturbances typically disappear under successful antidepressant medication (Ising et al., 2005).”
BackgroundSelf-citationImpact of glucocorticoid on neurogenesis
Numakawa, T., Odaka, H., & Adachi, N. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.211174 · Cited by 93
Wingenfeld, K., & Wolf, O. T. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.10.009 · Cited by 92
The DEX/CRH test for major depression: A potentially useful diagnostic test
Mokhtari, M., Arfken, C., & Boutros, N. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2012.09.032 · Cited by 79
Hohne, N., Poidinger, M., Merz, F., Pfister, H., Bruckl, T., Zimmermann, P., Uhr, M., Holsboer, F., & Ising, M. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu087 · Cited by 74
“…epigenetic modifications of FKBP5 and other stress-related genes (Menke et al., 2012a), which in turn contributes to the well-documented observation of an improved stress response regulation after successful depression therapy (Raison and Miller, 2003; Ising et al., 2005; Pariante, 2009).”
BackgroundSelf-citationLeistner, C., & Menke, A. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.01.023 · Cited by 69
FKBP5 Gene Expression Predicts Antidepressant Treatment Outcome in Depression
Ising, M., Maccarrone, G., Brückl, T., Scheuer, S., Hennings, J., Holsboer, F., Turck, C. W., Uhr, M., & Lucae, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030485 · Cited by 60
“In addition, previous studies using the combined dex/CRH test reported homogenous effects of effective antidepressant treatments on HPA axis regulation [11], which presumably can also be expected for FKBP51.”
Self-citationHorstmann, S., Dose, T., Lucae, S., Kloiber, S., Menke, A., Hennings, J., Spieler, D., Uhr, M., Holsboer, F., & Ising, M. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.09.004 · Cited by 44
“The combined dexamethasone (dex)/corticotrophin releasing hormone (CRH) test is to date the most sensitive neuroendocrine function test to pickup HPA axis dysregulation (Holsboer et al., 1987; Heuser et al., 1994a; Ising et al., 2005).”
BackgroundSelf-citationVasopressin V1B receptor antagonists as potential antidepressants
Chaki, S. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab013 · Cited by 34
Association of amygdala volumes with cortisol secretion in unipolar depressed patients
Schuhmacher, A., Mössner, R., Jessen, F., Scheef, L., Block, W., Belloche, A. C., Lennertz, L., Welper, H., Höfels, S., Pfeiffer, U., et al. (2012) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2011.09.007 · Cited by 25
Bschor, T., Ritter, D., Winkelmann, P., Erbe, S., Uhr, M., Ising, M., & Lewitzka, U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027613 · Cited by 23
“The combined DEX/CRH test was performed in accordance with the established research procedure [6,41,52,53,54]: The Lithium Treatment of Depression and DEX/CRH Test”
BackgroundMethodSelf-citationWingenfeld, K., Lange, W., Wulff, H., Berea, C., Beblo, T., Saavedra, A. S., Mensebach, C., & Driessen, M. (2007) · Journal of Clinical Psychology · doi:10.1002/jclp.20396 · Cited by 18
Hypothalamic stress systems in mood disorders
(2021) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-819973-2.00003-4 · Cited by 15
Self-citation
Metadata
- Authors
- Ising, M., Künzel, H. E., Binder, E. B., Nickel, T., Modell, S., & Holsboer, F.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 29
- Issue
- 6
- Pages
- 1085-1093
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2026131598
- Cited by
- 271
- References
- 64
- FWCI
- 7.92
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.